We Invest in
Exciting Companies
Learn moreAbout GWM
GWM is a private investment company. Our investment strategy focuses on promising growth companies, primarily within IT and Biotech.
GWM is an active owner who brings expertise and experience in building excellent growth companies. We invest where we are wanted as an active contributor. We put our experience and contacts to work for the best of all shareholders.
Capital funds originate from Gert W. Munthe’s tenure as CEO of NetCom ASA (1993-1998) and from his tenure as founder and managing partner of Herkules Capital (2002-2025).
Main Investments
A promising Pan Nordic IT company with an annual growth of ≈100%. Proprietary software for the distribution of electronic ads.
www.adnuntius.com
A novel and unique Biotech company. Patented substance for coating of MedTech equipment in order to secure a non-bacterial working environment
www.amicoat.com
Meet Our Team
Gert W. Munthe
Ola Skavlem
Helena Nyblom Munthe
Special Advisor
Helena Nyblom Munthe, MD, Ph. D. Dr Nyblom earned her MD and Ph D degrees from Sahlgrenska Akademiet at Gothenburg University. She has broad clinical experience in internal medicine and psychiatry. She is an acclaimed author with 5 published books which have aggregate sales in excess of 100 000 books. Her field of expertise is nutrition and wellness.
Amalie Haugen
Cases
We bring an outstanding track record in value creation within growth companies.
Herkules Capital
Gert, together with Ferd, established Herkules Capital in 2002. 4 funds with a aggregate capital of MNOK 15 000 were raised. Very competitive returns with approximately 3X blended return.
Netcom
Gert W Munthe served as CEO from August 1993 – June 1998. Gert monitored the design and roll-out of the national GSM network. A nationwide distribution network was established. NetCom took pride in being the innovative challenger. The company handled Norway’s first text message, SMS. The company launched voicemail, roaming, data packages and much more. Most importantly, Gert recruited outstanding people who were transformed into an innovative, forward thinking and cost conscious organization.NetCom went public in 1996, less than three years after commercial launch. Netcom secured the original investors approximately 70% annual return. The company was No. 9 in market cap on the Oslo stock exchange
Pronova
Gert managed the Pronova transaction where Herkules acquired Pronova from Norsk Hydro in 2003. The first Herkules investment. Following a strategic repositioning Pronova was split in two. Pronova building a global pharmaceutical grade Omega lll business. Epax building a consumer grade bulk business.Gert recruited an internationally recognized CEO with extensive pharmaceutical experience, primarily from Merck. The management team was recruited and expanded.Pronova was IPO’ed in 2007. The investment produced a 10+ X for the Herkules fund
The Board
Gert W. Munthe
Finn Kinserdal
Helena Nyblom Munthe
Special Advisor
Helena Nyblom Munthe, MD, Ph. D. Dr Nyblom earned her MD and Ph D degrees from Sahlgrenska Akademiet at Gothenburg University. She has broad clinical experience in internal medicine and psychiatry. She is an acclaimed author with 5 published books which have aggregate sales in excess of 100 000 books. Her field of expertise is nutrition and wellness.
Harald Willumsen
Former senior partner Wiersholm
Harald Willumsen is a former senior partner and Managing partner at Norway’s leading law firm Wiersholm
Get in Touch
Reach out by sending us an email
info@gwm.no